CFOs On the Move: Week Ending March 26
Condé Nast, Foot Locker, Velocity, Merck, DNA Script, Ibotta, Cano Health, Ring Energy, PG&E, Adobe
CFOs On the Move: Week Ending February 5
Merck, Fetch Rewards, L Brands, Royal Cup Coffee & Tea, The Children’s Place, SMART Global Holdings, RealNetworks, Idea Financial, Virta Health
Merck Drops Out of COVID-19 Vaccine Race
Merck's announcement that it is shelving its two vaccine candidates "marks a shocking setback for one of the most storied vaccine makers."
Merck Buys OncoImmune in COVID Treatment Move
The $425 million deal gives Merck access to a promising therapy for treating seriously ill COVID-19 patients.
Merck Enters Race to Develop COVID Vaccine
The world's largest vaccine maker is no longer on the COVID sidelines after acquiring an Austrian biotech and teaming up with a nonprofit.
Merck, Sanofi in Deals for Cancer Drug Firms
The pharma giants each announced they would buy smaller drugmakers to expand cancer-treatment franchises.
Merck Goes Hostile in Versum Takeover Battle
Versum shareholders are scheduled to vote next month on a merger with Entegris that is valued at less than Merck's $5.9 billion proposal.
Bayer to Shed Assets, Cut Jobs Amid Share Pressure
It's a broad restructuring of the German conglomerate, which plans to sell its sun-care and foot care businesses and exit its animal health division.
P&G Buys Merck Unit to Boost OTC Business
The $4 billion acquisition of Merck's consumer healthcare unit comes amid investor pressure on P&G to increase sales.
Data Held Hostage
The damage inflicted in this year’s ransomware attacks will force corporations to review their IT resilience.